Table 1.
General characteristics of and reasons for end of follow-up among patients using Covidom, as of May 19, 2020.
| Characteristic | Posthospital discharge management (n=5493) | Initial outpatient management (n=42,797) | Total (N=48,290) | ||
| General characteristics |
|
|
|||
|
|
Age (years), mean (SD) | 48.5 (17.2) | 42.3 (14.9) | 43.7 (15.8) | |
|
|
Gender, n (%) |
|
|
|
|
|
|
|
Male | 2669 (48.6) | 16,260 (38.0) | 23,564 (41.2) |
|
|
|
Female | 2818 (51.3) | 26,488 (61.9) | 33,542 (58.7) |
| Risk profile, n (%) |
|
|
|||
|
|
High-risk profile | 3315 (60.3) | 17,082 (39.9) | 24,756 (43.3) | |
| Reason for end of follow-up, n (%) |
|
|
|||
|
|
Automatic termination of follow-up after 30 days | 3957 (72.0) | 30,810 (72.0) | 34,767 (72. 0) | |
|
|
Follow-up ended early at patient’s requesta | 831 (15.1) | 7473 (17.5) | 8304 (17.2) | |
|
|
Ongoing follow-up | 590 (10.74) | 4046 (9.45) | 4636 (9.60) | |
|
|
Hospital admission | 111 (2.0) | 433 (1.0) | 544 (1.1) | |
|
|
Death | 4 (0.1) | 35 (0.1) | 39 (0.1) | |
aFollow-up ended early at patient’s request: no more symptoms, no longer felt like answering questionnaires, or any other reason left at the patient’s discretion.